✦ LIBER ✦

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C

✍ Scribed by Markus Reiser; Holger Hinrichsen; Yves Benhamou; Henk W. Reesink; Heiner Wedemeyer; Cristina Avendano; Neus Riba; Chan-Loi Yong; Gerhard Nehmiz; Gerhard G. Steinmann

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 196 KB
Volume: 41
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.20612

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determinants of relapse after a short (1

Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection

✍ Alessandra Mangia; Nicola Minerva; Donato Bacca; Raffaele Cozzolongo; Ernesto Ag 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

In hepatitis C virus (HCV) genotypes 2 and 3 patients, the high rate of relapse after 12 to 16 weeks of antiviral therapy is the main concern for shortening treatment duration. This study was undertaken to delineate predictors of relapse after short treatment in patients with undetectable HCV RNA at

Efficacy of interferon-based antiviral t

Efficacy of interferon-based antiviral therapy in patients with chronic hepatitis C infected with genotype 5: A meta-analysis of two large prospective clinical trials

✍ François D'Heygere; Christophe George; Hans Van Vlierberghe; Jochen Decaestecker 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract The characteristics and response rate to pegylated interferon and ribavirin (PEG‐INF + RBV) of patients with chronic hepatitis C infected with genotype 5 are poorly documented. A meta‐analysis of two large phase III/IV prospective randomized clinical trials conducted in Belgium in patie